Part One: Pediatric Heart Failure: Recent Updates and Future Directions
Part Two: Updates in Pediatric Severe Traumatic Brain Injury

• Series Overview
• Program Content
• Faculty
• Financial Relationship Disclosures
• Target Audience and Learning Objectives
• Continuing Pharmacy Education Credit
• BCPPS Specialty Recertification Credit
• Technical Requirements
• Commercial Support
• Fees

Clinical Reasoning Series in Pediatric Pharmacy has been approved by the Board of Pharmacy Specialties (BPS) as one component of the professional development programs developed by ACCP for recertification of the Board Certified Pediatric Pharmacy Specialist (BCPPS).

This educational series explores cutting-edge, contemporary therapeutic topics, and demonstrates scientifically sound clinical reasoning and decision-making. It employs learning activities designed to advance the participants' skills and abilities to critically evaluate the scientific evidence and to effectively incorporate into daily practice significant findings that lead to effective and safe patient care.

The program will consist of several educational activities and is presented in two parts with each part containing:

• streaming audio/slide synchronized presentations
• downloadable mp3 audio files
• downloadable mp4 video files
• downloadable/printable PDFs of presentation slides
• Continuing Pharmacy Education (CPE) credit
• Recertification Credit - Available with Specialty Recertification package.

Release date: November 9, 2022
BCPPS credit expiration date: November 9, 2023
ACPE credit expiration date: November 9, 2025

Part One: Pediatric Heart Failure: Recent Updates and Future Directions

Part one of the program will provide an overview of the most current guidelines for the treatment of pediatric heart failure as well as review new and upcoming novel agents for this disease state.

Part Two: Updates in Pediatric Severe Traumatic Brain Injury

Part two of the program will provide an overview of the most current guideline recommendations for treating traumatic brain injury.

Clinical Reasoning Series in Pediatric Pharmacy – Program Chair

	Morgan Alonzo, Pharm.D., BCACP Ambulatory Endocrinology Pharmacist Children's Hospital Colorado Anschutz Medical Campus Aurora, Colorado

Clinical Reasoning Series in Pediatric Pharmacy – Part One: Pediatric Heart Failure: Recent Updates and Future Directions

	Megan Greene, Pharm.D., BCPPS Ambulatory Cardiology Pharmacist Children's Hospital Colorado Anschutz Medical Campus Aurora, Colorado

Clinical Reasoning Series in Pediatric Pharmacy – Part Two: Updates in Pediatric Severe Traumatic Brain Injury

	Maura Harkin, Pharm.D., BCPPS Clinical Pharmacy Specialist, Pediatric Intensive Care Unit Oklahoma Children's Hospital Oklahoma City, Oklahoma

Disclosures 

TARGET AUDIENCE
The target audience for Clinical Reasoning Series in Pediatric Pharmacy is the pharmacist practicing in a clinical pediatric setting as a Board Certified Pediatric Pharmacy Specialist (BCPPS) looking to earn recertification credit, and those clinicians seeking additional information on the topics covered.

LEARNING OBJECTIVES
At the conclusion of Part One: Pediatric Heart Failure: Recent Updates and Future Directions, the participant should be able to:

1. Compare and contrast pediatric and adult guidelines for the pharmacologic management of heart failure (HF).
2. Evaluate available literature regarding new HF therapies and determine how it pertains to the pediatric patient population.
3. Develop a therapeutic plan for how to incorporate new HF therapies into the care of pediatric HF patients.

At the conclusion of Part Two: Updates in Pediatric Severe Traumatic Brain Injury, the participant should be able to:

1. Summarize guideline and consensus-based recommendations for therapeutic targets and baseline care for pediatric patients with severe traumatic brain injury (TBI).
2. Analyze patient-specific clinical data to select first and second tier therapies for pediatric patients with severe TBI.
3. Develop a complete therapeutic plan for pediatric patients with severe TBI, including monitoring and identifying need for escalation or weaning of therapy.

The American College of Clinical Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Clinical Reasoning Series in Pediatric Pharmacy – Part One: Pediatric Heart Failure: Recent Updates and Future Directions

Activity Number: 0217-0000-22-234-H01-P
Contact Hours: 3.00
Activity Type: Application-Based Activity

Clinical Reasoning Series in Pediatric Pharmacy – Part Two: Updates in Pediatric Severe Traumatic Brain Injury

Activity Number: 0217-0000-22-235-H01-P
Contact Hours: 3.00
Activity Type: Application-Based Activity

Methods and CE Requirements

ACPE Continuing Pharmacy Education Credit
To be eligible to earn continuing pharmacy education credit, participants must purchase the product, review all content, successfully complete, submit and pass the Web-based posttest associated with each module by November 9, 2025. Only completed assessments will be eligible for credit; no partial or incomplete assessments will be processed. You are allowed only one attempt to successfully complete this assessment.

National Association of Boards of Pharmacy - CPE Monitor Service

Provided through the collaborative efforts of the National Association of Boards of Pharmacy (NABP), the Accreditation Council for Pharmacy Education (ACPE), and ACPE-accredited providers, the CPE Monitor Service allows you to electronically keep track of continuing pharmacy education (CPE) credits from ACPE-accredited providers. ACPE-accredited providers, like ACCP, are responsible for transmitting this information to NABP to be stored in the CPE Monitor system. Statements of credit will be available at CPE Monitor, nabp.pharmacy/cpe-monitor-service/, within 2–3 business days after completion of this activity. For more information on CPE Monitor please visit nabp.pharmacy/cpe-monitor-service/.

To transfer these credits to CPE Monitor on your behalf your NABP e-Profile ID Number and date of birth must be listed on your ACCP account. To verify or update this information in your ACCP account, visit Licensure/Certification. Be sure to save your changes at the bottom of the page.

Some international pharmacists do not use the CPE Monitor service. To verify or update this information in your ACCP account, visit Licensure/Certification. Check the box “I am an international pharmacist or I am not licensed to practice in the United States, and do not have an NABP e-Profile ID.” Be sure to save your changes at the bottom of the page.

To be eligible to earn BCPPS recertification credit, participants must purchase the recertification version of this course, review all content, successfully complete, submit and pass the Web-based posttest associated with each module by November 9, 2023. Only completed assessments will be eligible for credit; no partial or incomplete assessments will be processed. You are allowed only one attempt to successfully complete this assessment.

The passing point to earn BCPPS recertification credit is based on an expert analysis of the assessment items in each posttest module. Any posttest submitted before the BCPPS posttest deadline that meets this passing point will earn BCPPS recertification credits. These credits will be assigned as of the date of test submission. For statements of recertification credit, visit www.bpsweb.org.

All participants must have a Board of Pharmacy Specialties (BPS) board certification credential number, BPS ID Number, and a BPS expiration date on file with ACCP for reporting purposes. To verify or update this information in your ACCP account, visit Licensure/Certification. Be sure to save your changes at the bottom of the page.

Questions regarding the number of hours required for BCPPS recertification should be directed to BPS at (202) 946-5026 or www.bpsweb.org. The ACCP Recertification Dashboard is a free online tool that can track recertification credits as they are earned through ACCP and schedule new opportunities for credits from upcoming ACCP professional development programs.

• Internet browser
• Adobe Reader (available free)

The American College of Clinical Pharmacy does not solicit or accept external commercial/financial support for its continuing pharmacy education activities. No commercial/financial support has been solicited or accepted for this activity.